BNTX

BNT122 (RO7198457)

Advanced Melanoma

Stage (next event)

Expected Date

Phase 2 to be initiated

H1 2021

Catalyst Info & Data Links

TITLE: BNT122 for Advanced Melanoma Phase 2 to be initiated

  • Clinical Trial (NCT03815058) A Study to Evaluate The Efficacy And Safety Of RO7198457 In Combination With Pembrolizumab Versus Pembrolizumab Alone In Participants With Previously Untreated Advanced Melanoma. (IMCODE001)


WHAT IS THE NEXT CATALYST EVENT?

  • Phase 2 to be initiated


WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?

  • H1 2021


PRIOR DATA/EVENTS

PRESS RELEASES

Mechanism of Action

Updated by MV

Prior Data (click to view full image)

Chart

Trial Design / Revenue (click to view full image)

Chart

Recent Posts

See what the community is saying - click to see full post

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon